Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
Medical experts testifying in malpractice suits for the defense tend to have higher objective indicators of erudition than peers testifying for the plaintiff. Radiologists buck this pattern.
Comparing six dual-energy CT technologies marketed by three scanner manufacturers, radiology researchers have found all models helpful in determining the chemical composition of kidney stones even at substantially reduced radiation doses.
The Internet is an acceptable source of images for training algorithms to automatically triage patients with dislocated joints and similar orthopedic emergencies.
As FDA-approved AI software continues to proliferate in radiology—well more than 150 products to date and rising—a trio of Yale radiologists has compiled a status report focused on AI applications available to, specifically, emergency radiology.
AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.
Researchers have developed a novel cardiovascular MRI protocol as an option to the invasive gold standard, endomyocardial biopsy, for monitoring heart-transplant patients at risk of suffering organ rejection.